scanUNIQUE Delta Set CA

128 Kinases You Can’t Get From The Next Leading Provider

When it comes to kinase selectivity and off-target profiling, kinase panel size matters! Larger panels provide not only a better measure of compound selectivity, but a more comprehensive view of potential off-target activity that smaller panels may overlook.

See for yourself how KINOMEscan compares to the competition using our scanUNIQUE Delta Set panels, or contact us to receive more information about the assays missing in your current solution provider's portfolio. Then request a quote to see what you're missing!
 

Panel Highlights and Benefits

  • 128 kinases not available from the next leading provider
  • Affords a comprehensive view of potential off-target activity that smaller panels may overlook
  • Avoid costly decisions or even lost opportunities due to incomplete data

 

Delta Set CA
Red circles represent unique KINOMEscan™ kinases not currently available from the next leading provider.

Case Study: Assessing Compound Selectivity & Potency Across Delta Set Ca Assays

 

Sunitinib


Sunitinib

Erlotinib


Erlotinib

Dasatinib


Dasatinib
Kd values < 3 µM for three FDA-approved kinase inhibitors across the 128 kinases not available from the next leading provider.

 

scanUNIQUE™, Delta Set CA - 128 Kinases
AAK1ACVR1ACVR1BACVR2AACVR2BACVRL1ADCK3ADCK4
ANKK1ASK2BIKEBMPR1BBMPR2BUB1CAMK1GCAMKK1
CAMKK2CASKCDC2L1CDC2L2CDC2L5CDK11CDK8CDKL1
CDKL2CDKL3CDKL5CLK4CSNK1A1LDAPK2DAPK3DCAMKL1
DCAMKL3DMPKDMPK2DRAK1DRAK2EIF2AK1EPHB6ERBB3
ERK3ERK4ERK8ERN1GAKGCN2(Kin.Dom.2,S808G)GRK1GRK4
GRK7HPK1HUNKICKIRAK3LATS1LIMK2LRRK2
LZKMAKMAP3K15MAP4K3MAP4K5MAST1MLCKMTOR
MYLKMYLK4MYO3AMYO3BNEK11NEK3NEK5NLK
OSR1PCTK1PCTK2PCTK3PFTAIRE2PFTK1PIK3C2BPIK3C2G
PIK3CBPIK3CDPIK3CGPIK4CBPIP5K1APIP5K1CPIP5K2BPIP5K2C
PKMYT1PKN2PRP4QSKRIOK1RIOK2RIOK3RIPK1
RIPK2RIPK4RIPK5SBK1SgK110SNRKSTK16STK33
STK35STK36STK39TAOK1TAOK3TESK1TGFBR1TGFBR2
TIE1TLK1TLK2TNNI3KTRPM6ULK1ULK2ULK3
VRK2WEE2YANK1YANK2YANK3YSK1YSK4ZAK